ONCOZ — Oncozenge AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK54.47m
- SEK50.60m
- SEK0.00m
Annual cashflow statement for Oncozenge AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 29 W | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PRESS | ARS | ARS | PRESS |
| Standards: | SAS | — | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.801 | -4.89 | -43.6 | -15.9 | -8.69 |
| Non-Cash Items | 0 | 0 | 23.5 | 0 | -0.003 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.8 | 0.127 | -1.97 | -1.18 | -0.076 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.001 | -4.77 | -22.1 | -17.1 | -8.76 |
| Other Investing Cash Flow Items | 0 | -5.36 | 0 | 0.57 | 0 |
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -5.36 | 0 | 0.57 | 0 |
| Financing Cash Flow Items | -0.5 | -8.74 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 10 | 51.3 | 0 | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10 | 41.2 | -22.1 | -16.5 | -8.76 |